+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Blood Screening Market by Technology (Nucleic Acid Amplification, (Real-Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Forecast to 2026

  • PDF Icon

    Report

  • 237 Pages
  • December 2021
  • Region: Global
  • Markets and Markets
  • ID: 5128931

The global blood screening market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4% during the forecast period. Growth in this market is mainly driven by the growing number of blood donations across the world, the rising prevalence of infectious diseases, and the rising demand for donated blood. 




The reagents & kits segment accounted for the highest growth rate in the blood screening market, by product & service, during the forecast period

The blood screening market is segmented into reagents & kits, instruments, and software & services based on product. In 2020, the reagents & kits segment accounted for the highest growth rate in the blood screening market. Market growth can largely be attributed to the rising number of blood transfusions and blood donations. In addition, technological advancements in blood screening technologies and the increasing number of surgeries are stimulating the growth of this segment.


Blood banks segment accounted for the highest CAGR

Based on end-users, the blood screening market is segmented into blood banks and hospitals. In 2020, the blood banks segment accounted for the highest growth rate. This can be attributed to the growing number of organ transplantation surgeries, and rising awareness about blood safety.


Asia Pacific: The fastest-growing region blood screening market

The global blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as the increasing healthcare spending, increasing government efforts to increase awareness about early disease detection, growing per capita income, expansion of private-sector hospitals to rural areas in various APAC countries, the rising geriatric population in several APAC countries (coupled with the increasing prevalence of chronic disorders), and the presence of high-growth markets in the region. The low labour costs and the favourable regulatory environment in this region are also expected to propel market growth.


The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:

  • Grifols (Spain)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott Laboratories, Inc. (US), bioMérieux (France)
  • Bio-Rad Laboratories, Inc. (US)
  • Becton, Dickinson and Company (US)
  • Beckman Coulter, Inc. (Danaher) (US)
  • DiaSorin (Italy)
  • Siemens Healthineers (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Ortho Clinical Diagnostics Inc. (US)
  • GE Healthcare (US)
  • Merck KGaA (Germany)
  • PerkinElmer (US)
  • Bio-Techne Corporation (US)
  • GFE (Germany)
  • Trinity Biotech (Ireland)
  • Mindray (China)
  • Maccura Biotechnology Co., Ltd. (China)
  • Immucor, Inc. (US)
  • Cellabs (Australia)
  • Abnova Corporation (Taiwan)
  • Enzo Biochem, Inc. (US)
  • Cepheid (US)

Research Coverage:

This report provides a detailed picture of the global blood screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technology, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.


Key Benefits of Buying this Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall blood screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.


Frequently Asked Questions about the Global Blood Screening Market

What is the estimated value of the Global Blood Screening Market?

The Global Blood Screening Market was estimated to be valued at $2.5 Billion in 2021.

What is the growth rate of the Global Blood Screening Market?

The growth rate of the Global Blood Screening Market is 8.4%, with an estimated value of $3.8 Billion by 2026.

What is the forecasted size of the Global Blood Screening Market?

The Global Blood Screening Market is estimated to be worth $3.8 Billion by 2026.

Who are the key companies in the Global Blood Screening Market?

Key companies in the Global Blood Screening Market include Abbott Laboratories, Abnova Corporation, Becton, Dickinson and Company, Biomérieux, Bio, Rad Laboratories, Bio, Techne Corporation and Cepheid.

Table of Contents

1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions of the Study
1.2.2 Markets Covered
Figure 1 Blood Screening Market Segmentation
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Summary of Changes
2. Research Methodology
2.1 Research Data
2.2 Research Approach
Figure 2 Blood Screening Market: Research Design
2.2.1 Secondary Data
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Data
2.2.2.1 Primary Sources
2.2.2.2 Key Data from Primary Sources
2.2.2.3 Key Industry Insights
2.2.2.4 Breakdown of Primary Interviews
Figure 3 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants (Blood Screening Market)
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.1.1 Approach 1: Company Revenue Estimation Approach
Figure 5 Bottom-Up Approach: Company Revenue Estimation Approach
2.3.1.2 Approach 2: Presentations of Companies and Primary Interviews
2.3.1.3 Growth Forecast
2.3.1.4 CAGR Projections
Figure 6 CAGR Projections: Supply-Side Analysis
2.3.2 Top-Down Approach
Figure 7 Blood Screening Market: Top-Down Approach
2.4 Market Breakdown & Data Triangulation
Figure 8 Data Triangulation Methodology
2.5 Market Share
2.6 Assumptions for the Study
2.7 Limitations
2.8 Risk Assessment
2.8.1 Risk Assessment: Blood Screening Market
2.9 Growth Rate Assumptions
2.10 COVID-19 Health Assessment
2.11 COVID-19 Economic Assessment
2.12 Assessment of the Impact of COVID-19 on the Economic Scenario
Figure 9 Criteria Impacting the Global Economy
Figure 10 Recovery Scenario of the Global Economy
2.13 Assessment of the Impact of COVID-19 on the Blood Screening Market
3. Executive Summary
Figure 11 Blood Screening Market, by Product & Service, 2021 Vs. 2026 (USD Million)
Figure 12 Blood Screening Market, by Technology, 2021 Vs. 2026 (USD Million)
Figure 13 Blood Screening Market, by End-user, 2021 Vs. 2026 (USD Million)
Figure 14 Blood Screening Market, by Region, 2021 Vs. 2026 (USD Million)
4. Premium Insights
4.1 Blood Screening Market Overview
Figure 15 Growing Number of Blood Donations and Increasing Prevalence of Infectious Diseases Drive Market Growth
4.2 Blood Screening Market Share, by Product & Service, 2021 Vs. 2026
Figure 16 Reagents & Kits Segment Will Continue to Dominate the Market in 2026
4.3 Blood Screening Market Share, by Technology, 2021 Vs. 2026
Figure 17 Nucleic Acid Test Segment to Dominate the Market During the Forecast Period
4.4 Blood Screening Market Share, by End-user, 2021 Vs. 2026
Figure 18 Blood Banks Segment to Continue to Dominate the Market in 2026
4.5 Blood Screening Market: Geographic Growth Opportunities
Figure 19 Asia-Pacific to Register the Highest Growth Rate in the Blood Screening Market During the Forecast Period
5. Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Blood Screening Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rising Number of Blood Donations
Table 1 Global Cancer Prevalence, 2018 Vs. 2025
5.2.1.2 Rising Prevalence of Infectious Diseases and Emergence of Newer Pathogens
5.2.2 Restraints
5.2.2.1 Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Technological Advancements
5.2.3.2 Emerging Economies Offer Lucrative Opportunities
5.2.4 Challenges
5.2.4.1 High Cost of Blood Screening Technologies
5.2.4.2 Usage of Low-Sensitivity Screening
5.3 Impact of COVID-19 on the Blood Screening Market
5.4 Pessimistic, Optimistic, and Realistic Scenarios
5.4.1 Blood Screening Market
Figure 21 Pessimistic Scenario
Figure 22 Optimistic Scenario
Figure 23 Realistic Scenario
5.5 Pricing Analysis
Table 2 Price of Blood Screening Products (2021)
5.6 Patent Analysis
5.6.1 Patent Analysis of Nat
5.6.2 Patent Analysis of Elisa
5.7 Trade Analysis
5.7.1 Trade Analysis for Diagnostic Reagents
Table 3 Import Data for Diagnostic or Laboratory Reagents on a Backing, Prepared Diagnostic or Laboratory Reagents, by Country, 2016-2020 (USD Million)
Table 4 Export Data for Diagnostic or Laboratory Reagents on a Backing, Prepared Diagnostic or Laboratory Reagents, by Country, 2016-2020 (USD Million)
5.8 Value Chain Analysis
Figure 24 Major Value is Added During the Manufacturing & Assembly Phase
5.9 Supply Chain Analysis
Figure 25 Blood Screening Market: Supply Chain Analysis
5.10 Ecosystem Analysis of the Blood Screening Market
Figure 26 Blood Screening Market: Ecosystem Analysis
5.10.1 Role in Ecosystem
5.11 Porter's Five Forces Analysis
Table 5 Blood Screening Market: Porter's Five Forces Analysis
5.11.1 Threat of New Entrants
5.11.2 Threat of Substitutes
5.11.3 Bargaining Power of Buyers
5.11.4 Bargaining Power of Suppliers
5.11.5 Degree of Competition
5.12 Regulatory Landscape
5.12.1 North America
5.12.1.1 US
5.12.1.2 Canada
5.12.2 Europe
5.12.3 Asia-Pacific
5.12.3.1 Japan
5.12.3.2 India
5.12.4 Latin America
5.12.4.1 Brazil
5.12.5 Middle East
5.13 Case Study Analysis
5.13.1 Case Study 1
5.13.2 Case Study 2
5.14 Technology Analysis
5.15 Trends/Disruptions Impacting the Business of Customers
5.15.1 Revenue Sources are Shifting Toward Technology-Based Solutions due to the COVID-19 Pandemic
Figure 27 Revenue Shift for the Blood Screening Market
6. Blood Screening Market, by Product & Service
6.1 Introduction
Table 6 Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
6.2 Reagents & Kits
Table 7 Key Products in the Reagents & Kits Market
Table 8 Blood Screening Reagents & Kits Market, by Region, 2019-2026 (USD Million)
Table 9 Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
6.2.1 Nat Reagents & Kits
6.2.1.1 High Sensitivity and Rising Use of Nat are Boosting the Demand for Reagents & Kits
6.2.1.2 Enzymes & Polymerases
6.2.1.3 Standards & Controls
6.2.1.4 Probes & Primers
6.2.1.5 Buffers, Nucleotides, and Solutions
6.2.1.6 Labeling & Detection Reagents
6.3 Primary Notes
6.3.1 Key Industry Insights
Table 10 Key Products in the Nat Reagents & Kits Market
Table 11 Nat Reagents & Kits Market, by Region, 2019-2026 (USD Million)
Table 12 Nat Reagents & Kits Market, by Type, 2019-2026 (USD Million)
6.3.2 Elisa Reagents & Kits
6.3.2.1 Ease of Use and Cost-Effectiveness of Elisa Reagents & Kits Will Drive the Market Growth
6.3.2.2 Immunosorbents
6.3.2.3 Controls
6.3.2.4 Conjugates
6.3.2.5 Substrates
6.3.2.6 Sample Diluents & Wash Solutions
Table 13 Key Products in the Elisa Reagents & Kits Market
Table 14 Elisa Reagents & Kits Market, by Region, 2019-2026 (USD Million)
Table 15 Elisa Reagents & Kits Market, by Type, 2019-2026 (USD Million)
6.3.3 Other Reagents & Kits
Table 16 Key Products in the Other Reagents & Kits Market
Table 17 Other Blood Screening Reagents & Kits Market, by Region, 2019-2026 (USD Million)
6.4 Instruments
Table 18 Key Products in the Blood Screening Instruments Market
Table 19 Blood Screening Instruments Market, by Region, 2019-2026 (USD Million)
Table 20 Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
6.4.1 Rental Purchase
6.4.1.1 Convenience and Cost-Effectiveness of Renting Instruments Has Resulted in a Greater End-User Preference
Table 21 Rental Purchase Market for Blood Screening Instruments, by Region, 2019-2026 (USD Million)
6.4.2 Outright Purchase
6.4.2.1 Availability of Government Support Will Increase the Outright Purchase of Instruments
Table 22 Outright Purchase Market for Blood Screening Instruments, by Region, 2019-2026 (USD Million)
6.5 Software & Services
6.5.1 Growing Purchase of Instruments Will Drive Demand for Software & Services
Table 23 Key Products in the Software & Services Market
Table 24 Blood Screening Software & Services, by Region, 2019-2026 (USD Million)
7. Blood Screening Market, by Technology
7.1 Introduction
Table 25 Blood Screening Market, by Technology, 2019-2026 (USD Million)
7.2 Nucleic Acid Test
Table 26 Key Products in the Nat Market
Table 27 Blood Screening Market for Nat, by Region, 2019-2026 (USD Million)
Table 28 Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
7.2.1 Transcription-Mediated Amplification
7.2.1.1 High Sensitivity of These Assays to Support the Market Growth
Table 29 Tma Market, by Region, 2019-2026 (USD Million)
7.2.2 Real-Time Polymerase Chain Reaction
7.2.2.1 Real-Time Pcr Provides More Accurate and Effective Results as Compared to Conventional Pcr
Table 30 Rt-Pcr Market, by Region, 2019-2026 (USD Million)
7.3 Enzyme-Linked Immunosorbent Assay
Table 31 Key Products in the Elisa Market
Table 32 Blood Screening Market for Elisa, by Region, 2019-2026 (USD Million)
Table 33 Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
7.3.1 Chemiluminescent Immunoassays
7.3.1.1 Clia is Ultra-Sensitive, Automated, and a Good Alternative to Conventional Technologies
Table 34 Clia Market, by Region, 2019-2026 (USD Million)
7.3.2 Fluorescent Immunoassays
7.3.2.1 Rising Demand for Safer and Stable Reagents and the Development of Novel Markers to Support the Growth of the Fia Market
Table 35 Fia Market, by Region, 2019-2026 (USD Million)
7.3.3 Colorimetric Immunoassays
7.3.3.1 Ci Offers Low Sensitivity as It Uses Vulnerable/Limited Signal Amplification Strategies
Table 36 Cia Market, by Region, 2019-2026 (USD Million)
7.4 Rapid Tests
7.4.1 Rising Awareness About Rapid Tests in Emerging Countries to Drive Market Growth
Table 37 Key Products in the Rapid Tests Technology Market
Table 38 Blood Screening Market for Rapid Tests, by Region, 2019-2026 (USD Million)
7.5 Western Blot Assays
7.5.1 Growing Prevalence of Ttis in Developing Countries Has Resulted in the Increased Demand for Western Blot Assays
Table 39 Key Products in the Western Blot Assays Market
Table 40 Blood Screening Market for Western Blot Assays, by Region, 2019-2026 (USD Million)
7.6 Next-Generation Sequencing
7.6.1 Ngs is an Emerging Technology in the Blood Screening Market
Table 41 Blood Screening Market for Ngs, by Region, 2019-2026 (USD Million)
8. Blood Screening Market, by End-user
8.1 Introduction
Table 42 Blood Screening Market, by End-user, 2019-2026 (USD Million)
8.2 Blood Banks
8.2.1 Rising Demand for Blood Attributed to Increasing Blood Disorder Incidence
8.2.2 Key Industry Insights
Table 43 Blood Screening Market for Blood Banks, by Region, 2019-2026 (USD Million)
8.3 Hospitals
8.3.1 Increasing Surgical Procedures Will Drive the Growth of the Hospitals Segment
Table 44 Blood Screening Market for Hospitals, by Region, 2019-2026 (USD Million)
9. Blood Screening Market, by Region
9.1 Introduction
Table 45 Blood Screening Market, by Region, 2019-2026 (USD Million)
9.2 North America
Figure 28 North America: Blood Screening Market Snapshot
Table 46 North America: Blood Screening Market, by Country, 2019-2026 (USD Million)
Table 47 North America: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 48 North America: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 49 North America: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 50 North America: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 51 North America: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 52 North America: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 53 North America: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.2.1 US
9.2.1.1 The Us Dominated the North American Blood Screening Market in 2020
Table 54 Incidence of Various Cancers in the Us, 2018 Vs. 2025
Table 55 US: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 56 US: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 57 US: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 58 US: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 59 US: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 60 US: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 61 US: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.2.2 Canada
9.2.2.1 Growing Volume of Surgical Procedures Performed and High Burden of Cancer to Support Market Growth
Table 62 Canada: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 63 Canada: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 64 Canada: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 65 Canada: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 66 Canada: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 67 Canada: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 68 Canada: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3 Europe
Table 69 Europe: Blood Screening Market, by Country, 2019-2026 (USD Million)
Table 70 Europe: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 71 Europe: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 72 Europe: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 73 Europe: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 74 Europe: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 75 Europe: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 76 Europe: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3.1 Germany
9.3.1.1 Higher Healthcare Spending and Increase in Cancer Prevalence Drives Market Growth
Table 77 Germany: Key Macroindicators
Table 78 Germany: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 79 Germany: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 80 Germany: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 81 Germany: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 82 Germany: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 83 Germany: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 84 Germany: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3.2 France
9.3.2.1 Increasing Prevalence of Hiv to Support the Market Growth
Table 85 France: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 86 France: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 87 France: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 88 France: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 89 France: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 90 France: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 91 France: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3.3 UK
9.3.3.1 Government Support to Prevent Transmission of Hiv and Other Infections Will Drive Market Growth
Table 92 UK: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 93 UK: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 94 UK: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 95 UK: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 96 UK: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 97 UK: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 98 UK: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3.4 Italy
9.3.4.1 Italy is Witnessing an Increase in the Number of Blood Donors
Table 99 Italy: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 100 Italy: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 101 Italy: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 102 Italy: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 103 Italy: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 104 Italy: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 105 Italy: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3.5 Spain
9.3.5.1 Increasing Adoption of Nat Technology Will Support Market Growth
Table 106 Spain: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 107 Spain: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 108 Spain: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 109 Spain: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 110 Spain: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 111 Spain: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 112 Spain: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.3.6 Rest of Europe
Table 113 Roe: Healthcare Expenditure, by Country, 2010 Vs. 2018 (% of Gdp)
Table 114 Roe: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 115 Roe: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 116 Roe: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 117 Roe: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 118 Roe: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 119 Roe: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 120 Roe: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.4 Asia-Pacific
Figure 29 Asia-Pacific: Blood Screening Market Snapshot
Table 121 Asia-Pacific: Blood Screening Market, by Country, 2019-2026 (USD Million)
Table 122 Asia-Pacific: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 123 Asia-Pacific: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 124 Asia-Pacific: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 125 Asia-Pacific: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 126 Asia-Pacific: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 127 Asia-Pacific: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 128 Asia-Pacific: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.4.1 China
9.4.1.1 China Has a High Prevalence of Infectious Diseases
Table 129 China: Key Macroindicators
Table 130 China: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 131 China: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 132 China: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 133 China: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 134 China: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 135 China: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 136 China: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.4.2 Japan
9.4.2.1 Rising Geriatric Population and Prevalence of Cancer Support Market Growth
Table 137 Japan: Key Macroindicators
Table 138 Japan: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 139 Japan: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 140 Japan: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 141 Japan: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 142 Japan: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 143 Japan: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 144 Japan: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.4.3 India
9.4.3.1 Increasing Number of Road Accidents and Rise in Prevalence of Thalassemia Will Support the Market Growth
Table 145 India: Key Macroindicators
Table 146 India: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 147 India: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 148 India: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 149 India: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 150 India: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 151 India: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 152 India: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.4.4 Australia
9.4.4.1 Increased Demand for Blood Donations Will Propel Market Growth
Table 153 Australia: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 154 Australia: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 155 Australia: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 156 Australia: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 157 Australia: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 158 Australia: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 159 Australia: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.4.5 Rest of Asia-Pacific
Table 160 Roapac: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 161 Roapac: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 162 Roapac: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 163 Roapac: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 164 Roapac: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 165 Roapac: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 166 Roapac: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.5 Latin America
Table 167 Latin America: Blood Screening Market, by Country, 2019-2026 (USD Million)
Table 168 Latin America: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 169 Latin America: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 170 Latin America: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 171 Latin America: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 172 Latin America: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 173 Latin America: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 174 Latin America: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.5.1 Brazil
9.5.1.1 Increased Prevalence of Cancer Will Support the Market Growth
Table 175 Incidence of Various Cancers in Brazil, 2020 Vs. 2025
Table 176 Brazil: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 177 Brazil: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 178 Brazil: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 179 Brazil: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 180 Brazil: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 181 Brazil: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 182 Brazil: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.5.2 Rest of Latin America
Table 183 Rolatam: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 184 Rolatam: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 185 Rolatam: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 186 Rolatam: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 187 Rolatam: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 188 Rolatam: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 189 Rolatam: Blood Screening Market, by End-user, 2019-2026 (USD Million)
9.6 Middle East & Africa
9.6.1 Rising Prevalence of Infectious Diseases and Strengthening of Healthcare Infrastructure to Support Market Growth
Table 190 Middle East & Africa: Blood Screening Market, by Technology, 2019-2026 (USD Million)
Table 191 Middle East & Africa: Blood Screening Market for Nat, by Type, 2019-2026 (USD Million)
Table 192 Middle East & Africa: Blood Screening Market for Elisa, by Platform, 2019-2026 (USD Million)
Table 193 Middle East & Africa: Blood Screening Market, by Product & Service, 2019-2026 (USD Million)
Table 194 Middle East & Africa: Blood Screening Reagents & Kits Market, by Type, 2019-2026 (USD Million)
Table 195 Middle East & Africa: Blood Screening Instruments Market, by Purchase Type, 2019-2026 (USD Million)
Table 196 Middle East & Africa: Blood Screening Market, by End-user, 2019-2026 (USD Million)
10. Competitive Landscape
10.1 Overview
10.2 Key Player Strategies/Right to Win
10.2.1 Overview of Strategies Deployed by Players in the Blood Screening Market
Table 197 Overview of Strategies Deployed by Key Blood Screening Manufacturing Companies
10.3 Revenue Share Analysis of Top Market Players
Figure 30 Revenue Share Analysis of the Top Players in the Blood Screening Market
10.4 Market Share Analysis
Figure 31 Blood Screening Market Share, by Key Player (2020)
Table 198 Blood Screening Market: Degree of Competition
10.5 Company Evaluation Quadrant
10.5.1 List of Evaluated Vendors
10.5.2 Stars
10.5.3 Emerging Leaders
10.5.4 Pervasive Players
10.5.5 Participants
Figure 32 Blood Screening Market: Competitive Leadership Mapping, 2020
10.6 Competitive Leadership Mapping for Startups/Smes (2020)
10.6.1 Progressive Companies
10.6.2 Starting Blocks
10.6.3 Responsive Companies
10.6.4 Dynamic Companies
Figure 33 Blood Screening Market: Competitive Leadership Mapping for Startups/Smes, 2020
10.7 Competitive Benchmarking
10.7.1 Product and Geographic Footprint Analysis
Figure 34 Product and Geographic Footprint Analysis of Top Players in the Blood Screening Market
Table 199 Product Footprint of Companies
Table 200 Regional Footprint of Companies
10.8 Competitive Scenario
10.8.1 Product Launches & Regulatory Approvals
Table 201 Key Product Launches
10.8.2 Deals
Table 202 Key Deals
11. Company Profiles
(Business Overview, Products, Key Insights, Recent Developments, Analyst's View)*
11.1 Key Players
11.1.1 F. Hoffmann-La Roche
Table 203 F. Hoffmann-La Roche: Business Overview
Figure 35 F. Hoffmann-La Roche: Company Snapshot (2020)
11.1.2 Grifols
Table 204 Grifols: Business Overview
Figure 36 Grifols: Company Snapshot (2020)
11.1.3 Abbott Laboratories
Table 205 Abbott Laboratories: Business Overview
Figure 37 Abbott Laboratories: Company Snapshot (2020)
11.1.4 Biomérieux
Table 206 Biomérieux: Business Overview
Figure 38 Biomérieux: Company Snapshot (2020)
11.1.5 Bio-Rad Laboratories
Table 207 Bio-Rad Laboratories: Business Overview
Figure 39 Bio-Rad Laboratories: Company Snapshot (2020)
11.1.6 Becton, Dickinson and Company
Table 208 Becton, Dickinson and Company: Business Overview
Figure 40 Bd: Company Snapshot (2020)
11.1.7 Danaher Corporation
Table 209 Danaher Corporation.: Business Overview
Figure 41 Danaher Corporation: Company Snapshot (2020)
11.1.8 Diasorin
Table 210 Diasorin: Business Overview
Figure 42 Diasorin: Company Snapshot (2020)
11.1.9 Siemens Healthineers
Table 211 Siemens Healthineers: Business Overview
Figure 43 Siemens Healthineers: Company Snapshot (2020)
11.1.10 Thermo Fisher Scientific, Inc.
Table 212 Thermo Fisher Scientific: Business Overview
Figure 44 Thermo Fisher Scientific: Company Snapshot (2020)
(Business Overview, Products, Key Insights, Recent Developments, Analyst's View)*
11.2 Other Players
11.2.1 Ortho Clinical Diagnostics, Inc.
11.2.2 GE Healthcare
11.2.3 Merck KGaA
11.2.4 Perkinelmer
11.2.5 Bio-Techne Corporation
11.2.6 Gfe
11.2.7 Trinity Biotech
11.2.8 J. Mitra & Co. Pvt. Ltd.
11.2.9 Mindray
11.2.10 Maccura Biotechnology Co., Ltd.
11.2.11 Immucor, Inc.
11.2.12 Cellabs
11.2.13 Abnova Corporation
11.2.14 Enzo Biochem, Inc.
11.2.15 Cepheid
12. Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations

Executive Summary

Companies Mentioned

  •  
  • Abbott Laboratories
  • Abnova Corporation
  • Becton, Dickinson and Company
  • Biomérieux
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cellabs
  • Cepheid
  • Danaher Corporation
  • Diasorin
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Gfe
  • Grifols
  • Immucor, Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Maccura Biotechnology Co., Ltd.
  • Merck KGaA
  • Mindray
  • Ortho Clinical Diagnostics, Inc.
  • Perkinelmer
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech

Methodology

Loading
LOADING...